Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 9 Beta Arabinofuranosyladenine
2. 9 Beta D Arabinofuranosyladenine
3. 9-beta-arabinofuranosyladenine
4. 9-beta-d-arabinofuranosyladenine
5. Adenine Arabinoside
6. Alpha Ara A
7. Alpha D Arabinofuranosyladenine
8. Alpha-ara A
9. Alpha-d-arabinofuranosyladenine
10. Ara A
11. Ara-a
12. Arabinofuranosyladenine
13. Arabinoside, Adenine
14. Arabinosyladenine
15. Beta Ara A
16. Beta-ara A
17. Vidarabine
18. Vira A
19. Vira-a
20. Viraa
1. 24356-66-9
2. Fa2dm6879k
3. Ci 673
4. Vidarabine (usan)
5. (2r,3s,4s,5r)-2-(6-amino-9h-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol Hydrate
6. Vidarabine [usan]
7. (2r,3s,4s,5r)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;hydrate
8. Vidarabine [jan]
9. Vidarabine (monohydrate)
10. (2r,3s,4s,5r)-2-(6-amino-9h-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol Hydrate
11. Adenine Arabinofuranoside Hydrate
12. 9-beta-d-arabinofuranosyl-9h-purine-6-amine Monohydrate
13. Drg-0058
14. Unii-fa2dm6879k
15. 9-beta-d-arabinofuranosyladenine Monohydrate
16. Vidarabineh2o
17. Vidarabine H2o
18. Adenine, 9-beta-d-arabinofuranosyl-, Monohydrate
19. Vidarabine [usan:usp:inn:ban:jan]
20. 9h-purin-6-amine, 9-beta-d-arabinofuranosyl-, Monohydrate
21. Vira-a (tn)
22. Vidarabine [vandf]
23. Schembl2929
24. Vidarabine [mart.]
25. Chebi:9978
26. Vidarabine [orange Book]
27. Dtxsid10947210
28. Vidarabine [usp Impurity]
29. 9h-purin-6-amine, 9-.beta.-d-arabinofuranosyl-, Monohydrate
30. Vidarabine Monohydrate [mi]
31. Hy-n6666
32. Mfcd00150980
33. S5297
34. Akos025312428
35. Ccg-267319
36. Nsc 757383
37. Cs-0083211
38. 9-beta-d-arabino Furanosyl Adenine Monohydrate
39. Adenine 9-beta-d-arabinofuranoside Monohydrate
40. C07195
41. D00406
42. T72143
43. Vidarabine (200 Mg)g-2939ug/mg(ai)
44. 9-pentofuranosyl-9h-purin-6-amine--water (1/1)
45. J-015462
46. 9-.beta.-d-arabinofuranosyladenine Monohydrate
47. 9h-purin-6-amine,9-b-d-arabinofuranosyl-,hydrate(1:1)
Molecular Weight | 285.26 g/mol |
---|---|
Molecular Formula | C10H15N5O5 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 2 |
Exact Mass | 285.10731860 g/mol |
Monoisotopic Mass | 285.10731860 g/mol |
Topological Polar Surface Area | 141 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 335 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Antimetabolites
Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Antimetabolites.)
Antiviral Agents
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)
ABOUT THIS PAGE
A Vidarabine Monohydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vidarabine Monohydrate, including repackagers and relabelers. The FDA regulates Vidarabine Monohydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vidarabine Monohydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Vidarabine Monohydrate supplier is an individual or a company that provides Vidarabine Monohydrate active pharmaceutical ingredient (API) or Vidarabine Monohydrate finished formulations upon request. The Vidarabine Monohydrate suppliers may include Vidarabine Monohydrate API manufacturers, exporters, distributors and traders.
Vidarabine Monohydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vidarabine Monohydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vidarabine Monohydrate GMP manufacturer or Vidarabine Monohydrate GMP API supplier for your needs.
A Vidarabine Monohydrate CoA (Certificate of Analysis) is a formal document that attests to Vidarabine Monohydrate's compliance with Vidarabine Monohydrate specifications and serves as a tool for batch-level quality control.
Vidarabine Monohydrate CoA mostly includes findings from lab analyses of a specific batch. For each Vidarabine Monohydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vidarabine Monohydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Vidarabine Monohydrate EP), Vidarabine Monohydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vidarabine Monohydrate USP).
LOOKING FOR A SUPPLIER?